Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: 360iResearch | PRODUCT CODE: 1318046

Cover Image

PUBLISHER: 360iResearch | PRODUCT CODE: 1318046

Contraceptive Market by Drugs, Gender, Distribution - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

PUBLISHED:
PAGES: 199 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF, Excel & Online Access - 1 Year (Single User License)
USD 4749
PDF, Excel & Online Access - 1 Year (Up to 5 User License)
USD 5749
PDF, Excel & Online Access - 1 Year (Site License)
USD 6749
PDF, Excel & Online Access - 1 Year (Enterprise User License)
USD 8749

Add to Cart

The Global Contraceptive Market is forecasted to grow significantly, with a projected USD 73.96 billion in 2023 at a CAGR of 19.36% and expected to reach a staggering USD 255.58 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Contraceptive Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Contraceptive Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Drugs, market is studied across Contraceptive Injectable, Emergency Contraceptive Pills, Oral Contraceptives, and Transdermal Patches. The Contraceptive Injectable is projected to witness significant market share during forecast period.

Based on Gender, market is studied across Female Contraceptive Devices and Male Contraceptive Devices. The Female Contraceptive Devices is projected to witness significant market share during forecast period.

Based on Distribution, market is studied across Clinics, Hospital Pharmacy, Independent Pharmacy, and Online Platform. The Clinics is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Contraceptive Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Contraceptive Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Contraceptive Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Contraceptive Market?

4. What is the competitive strategic window for opportunities in the Global Contraceptive Market?

5. What are the technology trends and regulatory frameworks in the Global Contraceptive Market?

6. What is the market share of the leading vendors in the Global Contraceptive Market?

7. What modes and strategic moves are considered suitable for entering the Global Contraceptive Market?

Product Code: MRR-4316E4E895CE

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Contraceptive Market, by Drugs, 2022 vs 2030
  • 4.3. Contraceptive Market, by Gender, 2022 vs 2030
  • 4.4. Contraceptive Market, by Distribution, 2022 vs 2030
  • 4.5. Contraceptive Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing incidence of unwanted pregnancies and sexually transmitted diseases
      • 5.1.1.2. Rising government initiatives to promote awareness regarding unintended pregnancies and increasing population
      • 5.1.1.3. Popularity of oral contraceptive pills in women of reproductive age
    • 5.1.2. Restraints
      • 5.1.2.1. Side effects of oral contraceptive drugs
    • 5.1.3. Opportunities
      • 5.1.3.1. Government and non-government organizations supporting programs to encourage contraception in emerging economies
      • 5.1.3.2. Introduction of affordable contraceptives method such as Sino-Implants and novel contraceptive
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of information and misconceptions about different contraceptives
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Contraceptive Market, by Drugs

  • 6.1. Introduction
  • 6.2. Contraceptive Injectable
  • 6.3. Emergency Contraceptive Pills
  • 6.4. Oral Contraceptives
  • 6.5. Transdermal Patches

7. Contraceptive Market, by Gender

  • 7.1. Introduction
  • 7.2. Female Contraceptive Devices
  • 7.3. Male Contraceptive Devices

8. Contraceptive Market, by Distribution

  • 8.1. Introduction
  • 8.2. Clinics
  • 8.3. Hospital Pharmacy
  • 8.4. Independent Pharmacy
  • 8.5. Online Platform

9. Americas Contraceptive Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Contraceptive Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Contraceptive Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing
Product Code: MRR-4316E4E895CE

LIST OF FIGURES

  • FIGURE 1. CONTRACEPTIVE MARKET RESEARCH PROCESS
  • FIGURE 2. CONTRACEPTIVE MARKET SIZE, 2022 VS 2030
  • FIGURE 3. CONTRACEPTIVE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2022 VS 2030 (%)
  • FIGURE 5. CONTRACEPTIVE MARKET SIZE, BY GENDER, 2022 VS 2030 (%)
  • FIGURE 6. CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2022 VS 2030 (%)
  • FIGURE 7. CONTRACEPTIVE MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. CONTRACEPTIVE MARKET DYNAMICS
  • FIGURE 9. CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. CONTRACEPTIVE MARKET SIZE, BY GENDER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. CONTRACEPTIVE MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. CONTRACEPTIVE MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. CONTRACEPTIVE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. CONTRACEPTIVE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 5. CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. CONTRACEPTIVE MARKET SIZE, BY EMERGENCY CONTRACEPTIVE PILLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. CONTRACEPTIVE MARKET SIZE, BY ORAL CONTRACEPTIVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. CONTRACEPTIVE MARKET SIZE, BY TRANSDERMAL PATCHES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 10. CONTRACEPTIVE MARKET SIZE, BY FEMALE CONTRACEPTIVE DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. CONTRACEPTIVE MARKET SIZE, BY MALE CONTRACEPTIVE DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 13. CONTRACEPTIVE MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. CONTRACEPTIVE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. CONTRACEPTIVE MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. CONTRACEPTIVE MARKET SIZE, BY ONLINE PLATFORM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 144. CONTRACEPTIVE MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 145. CONTRACEPTIVE MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 146. CONTRACEPTIVE MARKET LICENSE & PRICING
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!